Glem Lin 25/5Mg
Glimepiride/linagliptin combination for type 2 diabetes.
Glem Lin combines Glimepiride (sulfonylurea) and Linagliptin (DPP-4 inhibitor) for type 2 diabetes when dual therapy is indicated. Glimepiride stimulates insulin release; linagliptin increases incretin activity.
Purpose
Type 2 diabetes with diet and exercise when dual therapy with sulfonylurea and DPP-4 inhibitor is indicated.
Ingredients
Glimepiride 2.5mg (or as per strength), Linagliptin 5mg
Warnings
Hypoglycaemia risk with glimepiride. Not for type 1 diabetes or DKA. Prescription only.
Side Effects
Hypoglycaemia (from glimepiride), headache, nasopharyngitis. Linagliptin has low hypoglycaemia risk when used alone.
Storage Instructions
Store below 30°C. Keep in original pack. Protect from moisture.
| Brand | Nabiqasim |
| Status | Active |
Related Products
